NCS Group Asks DRG Adjustments For Institutions With Peer reviewed Components, 25 Protocol Patients
In Brief: Clark, Hutchinson Gain New Honors; Nominations Open For Bristol-Myers Award; NIH Appointments
GAO Finds Little Wrong With Drug Testing Program, But Offers Some Suggestions Anyways
NCAB Committee Approves Concepts For Recompetition Of CIDAC, Two Other Contracts
Trending Stories
- The story of daraxonrasib is the ultimate hero’s journey
A narrative curve with twists, turns, intrigue, drama—and a blow to a mighty foe - As his Senate testimony alleged danger from mRNA COVID vaccine, El-Deiry had an offer to run NCI Frederick lab
The job offer to run the lab—home to virus research, RAS Initiative, and data science—was quickly rescinded - Pancreatic cancer breakthrough came from smart scientists making smart bets—not from politicization of science
- At Senate hearing, Brown’s El-Deiry and other witnesses say they were targeted for arguing that mRNA vaccine may be linked to cancer
- Pancreatic cancer finally starts to budge as daraxonrasib doubles overall survival
- Proposed OMB rule aims at the heart of the U.S. research enterprise—and scientists are fighting back
“The question isn’t whether politics will influence research. Under this proposal, that’s the point. That’s their goal.”
